Hubei Biocause Pharmaceutical Co., Ltd.
SZSE:000627.SZ
3.1 (CNY) • At close October 26, 2023
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 49,698.874 | 49,615.695 | 49,583.191 | 43,575.987 | 50,192.084 | 30,950.844 | 53,405.58 | 16,995.546 | 541.107 | 806.443 | 967.951 | 779.736 | 1,133.763 | 1,261.159 | 964.603 | 909.282 | 835.759 | 560.754 | 518.725 | 463.046 | 422.679 | 348.61 | 356.012 | 321.963 | 255.863 | 192.314 | 237.532 | 143.724 | 83.266 |
Cost of Revenue
| 9,829.634 | 8,458.558 | 7,311.617 | 3,225.146 | 8,172.631 | 2,866.938 | 4,036.64 | 1,788.501 | 517.972 | 829.793 | 977.503 | 753.222 | 1,111.778 | 1,185.832 | 866.155 | 835.104 | 726.057 | 475.618 | 451.059 | 410.573 | 380.848 | 268.667 | 261.152 | 240.16 | 193.047 | 155.312 | 176.371 | 98.174 | 53.942 |
Gross Profit
| 39,869.24 | 41,157.137 | 42,271.573 | 40,350.84 | 42,019.454 | 28,083.907 | 49,368.94 | 15,207.045 | 23.135 | -23.35 | -9.552 | 26.514 | 21.986 | 75.327 | 98.448 | 74.179 | 109.702 | 85.135 | 67.666 | 52.473 | 41.83 | 79.943 | 94.86 | 81.804 | 62.816 | 37.002 | 61.161 | 45.55 | 29.324 |
Gross Profit Ratio
| 0.802 | 0.83 | 0.853 | 0.926 | 0.837 | 0.907 | 0.924 | 0.895 | 0.043 | -0.029 | -0.01 | 0.034 | 0.019 | 0.06 | 0.102 | 0.082 | 0.131 | 0.152 | 0.13 | 0.113 | 0.099 | 0.229 | 0.266 | 0.254 | 0.246 | 0.192 | 0.257 | 0.317 | 0.352 |
Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 5.662 | 19.221 | 15.538 | 11.421 | 6.838 | 6.537 | 6.5 | 5.976 | 7.973 | 5.514 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 1,765.119 | 333.971 | 541.056 | 628.195 | 600.752 | 500.292 | 498.724 | 550.043 | 18.343 | 12.94 | 15.05 | 11.922 | 21.909 | 21.459 | 42.866 | 49.858 | 40.354 | 32.485 | 33.994 | 32.349 | 49.679 | 42.313 | 14.936 | 9.778 | 21.808 | 8.846 | 8.221 | 8.254 | 5.682 |
Selling & Marketing Expenses
| -1,291.42 | 448.028 | 684.949 | 406.13 | 596.878 | 201.446 | 275.208 | 160.767 | 14.293 | 13.59 | 12.852 | 11.228 | 11.768 | 7.383 | 9.116 | 6.853 | 12.233 | 11.787 | 13.563 | 17.575 | 32.275 | 13.274 | 15.733 | 12.236 | 13.045 | 3.384 | 1.24 | 1.451 | 0.853 |
SG&A
| 473.699 | 333.971 | 541.056 | 628.195 | 600.752 | 500.292 | 498.724 | 550.043 | 32.636 | 26.531 | 27.902 | 23.151 | 33.677 | 28.842 | 51.982 | 56.711 | 52.587 | 44.272 | 47.557 | 49.924 | 81.954 | 55.587 | 30.669 | 22.014 | 34.853 | 12.23 | 9.461 | 9.706 | 6.535 |
Other Expenses
| 41,236.39 | 9,825.533 | 9,896.828 | 36,146.504 | 30,062.054 | -24,280.274 | -23,688.297 | -6,190.388 | 3.116 | 8.31 | 13.155 | 1.453 | 0.272 | 9.834 | 6.013 | 5.026 | 5.988 | 10.315 | 4.736 | 9.482 | 1.506 | 2.583 | 8.299 | 7.332 | 20.607 | 11.931 | 5.646 | 6.63 | 1.992 |
Operating Expenses
| 41,710.089 | 10,159.505 | 10,437.885 | 36,774.699 | 30,668.467 | 2,614.668 | 26,760.95 | 6,911.444 | 79.627 | 70.881 | 73.644 | 63.884 | 80.21 | 67.877 | 52.834 | 58.96 | 55.383 | 45.932 | 49.33 | 50.759 | 83.368 | 56.961 | 44.981 | 36.557 | 36.162 | 12.975 | 9.974 | 10.323 | 6.803 |
Operating Income
| 1,216.254 | 31,188.832 | 32,917.034 | 3,881.543 | 12,052.782 | 2,653.573 | 2,727.391 | 3,424.804 | 332.193 | 101.066 | -141.106 | 14.91 | -113.674 | 22.22 | 53.196 | 2.287 | 106.433 | 53.126 | 8.22 | -1.719 | -45.073 | 15.839 | 57.476 | 48.281 | 41.765 | 30.705 | 63.078 | 48.593 | 30.778 |
Operating Income Ratio
| 0.024 | 0.629 | 0.664 | 0.089 | 0.24 | 0.086 | 0.051 | 0.202 | 0.614 | 0.125 | -0.146 | 0.019 | -0.1 | 0.018 | 0.055 | 0.003 | 0.127 | 0.095 | 0.016 | -0.004 | -0.107 | 0.045 | 0.161 | 0.15 | 0.163 | 0.16 | 0.266 | 0.338 | 0.37 |
Total Other Income Expenses Net
| -3,084.292 | -30,964.053 | -32,573.911 | -2,432.081 | -8,419.338 | -17.223 | -3.085 | -782.689 | 2.241 | 7.885 | 12.542 | 0.087 | -49.171 | 8.841 | 6.013 | 5.026 | 48.45 | 16.549 | -14.43 | 6.726 | -2.236 | 0.323 | 0.226 | 0.579 | 5.811 | 9.723 | 0.179 | 1.664 | -0.023 |
Income Before Tax
| -1,868.039 | 224.778 | 343.123 | 1,449.461 | 3,633.444 | 2,636.35 | 2,724.307 | 3,432.561 | 334.433 | 108.951 | -128.564 | 14.997 | -116.678 | 31.061 | 59.209 | 7.313 | 112.421 | 57.945 | 8.431 | 5.007 | -47.309 | 16.162 | 57.702 | 48.86 | 47.576 | 39.748 | 63.257 | 50.256 | 30.755 |
Income Before Tax Ratio
| -0.038 | 0.005 | 0.007 | 0.033 | 0.072 | 0.085 | 0.051 | 0.202 | 0.618 | 0.135 | -0.133 | 0.019 | -0.103 | 0.025 | 0.061 | 0.008 | 0.135 | 0.103 | 0.016 | 0.011 | -0.112 | 0.046 | 0.162 | 0.152 | 0.186 | 0.207 | 0.266 | 0.35 | 0.369 |
Income Tax Expense
| -586.505 | -285.842 | -537.095 | 331.556 | 714.891 | 259.09 | 46.02 | 323.719 | 83.895 | 24.834 | -28.115 | 1.191 | -9.499 | 1.976 | 3.915 | -0.074 | 20.47 | 4.814 | 0.329 | 0.072 | 1.739 | 8.336 | 11.001 | 8.511 | 12.199 | 9.247 | 8.484 | 13.36 | 7.988 |
Net Income
| -651.759 | 510.62 | 880.218 | 1,117.906 | 2,918.553 | 1,326.52 | 1,326.164 | 1,778.719 | 247.267 | 83.823 | -101.011 | 11.825 | -101.684 | 28.322 | 55.762 | -23.818 | 89.708 | 48.366 | 7.099 | 5.09 | -48.106 | 5.261 | 37.227 | 34.243 | 31.343 | 30.23 | 54.773 | 36.896 | 22.767 |
Net Income Ratio
| -0.013 | 0.01 | 0.018 | 0.026 | 0.058 | 0.043 | 0.025 | 0.105 | 0.457 | 0.104 | -0.104 | 0.015 | -0.09 | 0.022 | 0.058 | -0.026 | 0.107 | 0.086 | 0.014 | 0.011 | -0.114 | 0.015 | 0.105 | 0.106 | 0.122 | 0.157 | 0.231 | 0.257 | 0.273 |
EPS
| -0.13 | 0.1 | 0.18 | 0.23 | 0.59 | 0.27 | 0.3 | 0.44 | 0.18 | 0.06 | -0.075 | 0.009 | -0.075 | 0.021 | 0.037 | -0.019 | 0.091 | 0.045 | 0.007 | 0.004 | -0.082 | 0.004 | 0.026 | 0.026 | 0.022 | 0.021 | 0.049 | 0.033 | 0.039 |
EPS Diluted
| -0.13 | 0.1 | 0.18 | 0.23 | 0.59 | 0.27 | 0.3 | 0.44 | 0.18 | 0.06 | -0.075 | 0.009 | -0.075 | 0.021 | 0.037 | -0.019 | 0.091 | 0.045 | 0.007 | 0.004 | -0.082 | 0.004 | 0.026 | 0.026 | 0.022 | 0.021 | 0.049 | 0.033 | 0.039 |
EBITDA
| 1,216.254 | 726.531 | 31,981.628 | 2,932.288 | 3,677.29 | 2,709.997 | 2,660.859 | 2,864.931 | 423.781 | 213.038 | -30.557 | 134.214 | -32.114 | 73.694 | 135.157 | 81.093 | 187.008 | 109.481 | 60.324 | 55.095 | 2.37 | 64.114 | 95.089 | 87.765 | 51.726 | 36.719 | 51.187 | 35.227 | 22.521 |
EBITDA Ratio
| 0.024 | 0.632 | 0.667 | 0.091 | 0.242 | 0.93 | 0.461 | 0.517 | 1.029 | 0.374 | -0.001 | 0.153 | -0.016 | 0.106 | 0.141 | 0.06 | 0.156 | 0.196 | 0.116 | 0.118 | 0.006 | 0.184 | 0.27 | 0.267 | 0.202 | 0.193 | 0.215 | 0.245 | 0.27 |